Ionis Pharmaceuticals (NASDAQ:IONS) reported Q1 2018 earnings this Morning, coming in at ($0.01) per share, missing Wall Street’s estimates of $0.04 per Share. Revenue for the quarter came in at $144.40 million beating analyst estimates of $144.01 million Recent Insider Trading for Ionis Pharmaceuticals (NASDAQ:IONS)
- On 4/17/2018 Stanley T Crooke, Chairman, sold 13,962 with an average share price of $44.40 per share and the total transaction amounting to $619,912.80.
- On 3/29/2018 Joseph Klein III, Director, sold 2,000 with an average share price of $46.15 per share and the total transaction amounting to $92,300.00.
- On 3/15/2018 Joseph Klein III, Director, sold 2,000 with an average share price of $51.13 per share and the total transaction amounting to $102,260.00.
- On 3/12/2018 Patrick R O’neil, SVP, sold 1,000 with an average share price of $55.00 per share and the total transaction amounting to $55,000.00.
- On 2/28/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $51.91 per share and the total transaction amounting to $155,730.00.
- On 2/15/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $48.99 per share and the total transaction amounting to $146,970.00.
Dividend History for Ionis Pharmaceuticals (NASDAQ:IONS)
Recent Trading for Ionis Pharmaceuticals (NASDAQ:IONS) Shares of Ionis Pharmaceuticals closed the previous trading session at 43.71 up +2.44 5.91% with 41.83000183105469 shares trading hands.